1. Stroosma OB, Schurink GW, Smits JM, Kootstra G. Transplanting horseshoe kidneys: a worldwide survey. J Urol. 2001; 166:2039–2042.
2. Zipitis CS, Augustine T, Tavakoli A, Surange R, Agrawal A, Riad HN. Horseshoe kidney transplantation. Surgeon. 2003; 1:160–163.
3. Weizer AZ, Silverstein AD, Auge BK, Delvecchio FC, Raj G, Albala DM, Leder R, Preminger GM. Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol. 2003; 170:1722–1726.
4. Wein AJ, Kavoussi LR, Campbell MF, Walsh PC. Campbell-Walsh urology. 10th ed. Philadelphia: Elsevier Saunders;2012.
5. Stroosma OB, Scheltinga MR, Stubenitsky BM, Kootstra G. Horseshoe kidney transplantation: an overview. Clin Transplant. 2000; 14:515–519.
6. O'Brien J, Buckley O, Doody O, Ward E, Persaud T, Torreggiani W. Imaging of horseshoe kidneys and their complications. J Med Imaging Radiat Oncol. 2008; 52:216–226.
7. Strauss S, Dushnitsky T, Peer A, Manor H, Libson E, Lebensart PD. Sonographic features of horseshoe kidney: review of 34 patients. J Ultrasound Med. 2000; 19:27–31.
8. Stroosma OB, Smits JM, Schurink GW, de Boer J, Persijn GG, Kootstra G. Horseshoe kidney transplantation within the eurotransplant region: a case control study. Transplantation. 2001; 72:1930–1933.
9. Goyal A, Gaitonde K, Sagade SN, Shah BV, Kamat MH. Transplantation of horseshoe kidney from living-related donors: report of two cases. Transplant Proc. 2003; 35:32–34.
10. Salehipour M, Bahador A, Salahi H, Nikeghbalian S, Jalaeian H, Davari HR, Malek-Hosseini SA. Transplantation of a horseshoe kidney. Arch Iran Med. 2007; 10:239–241.
11. Neville H, Ritchey ML, Shamberger RC, Haase G, Perlman S, Yoshioka T. The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG). J Pediatr Surg. 2002; 37:1134–1137.
12. Lee SH, Bae MH, Choi SH, Lee JS, Cho YS, Joo KJ, Kwon CH, Park HJ. Wilms' tumor in a horseshoe kidney. Korean J Urol. 2012; 53:577–580.
13. Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005; 80:883–889.